Pharmacy, Pharmaceutical Sciences, and Administration graduates from Roseman University of Health Sciences earn $141,336 median salary — above the national average for this program. Median debt: $233,933.
Pharmacy, Pharmaceutical Sciences, and Administration at Roseman University of Health Sciences
Henderson, Nevada • Doctoral
What the IPEDS & College Scorecard Data Shows for Pharmacy, Pharmaceutical Sciences, and Administration at Roseman University of Health Sciences
This page combines two federal data products: IPEDS institutional characteristics for Roseman University of Health Sciences and the College Scorecard field-of-study (FOS) file for Pharmacy, Pharmaceutical Sciences, and Administration at the doctoral credential level. The FOS file is keyed by CIP (Classification of Instructional Programs) code, which means earnings and debt figures here reflect only graduates of this specific program — not the school as a whole. Completer counts for the most recent cohort are not currently reported for this program-school pairing.
Median graduate earnings of $141,336 represent Treasury-verified wages approximately one year after program completion, drawn from Social Security Administration records linked to federal financial aid applicants. Compared to the national mean of $137,435 across all institutions offering Pharmacy, Pharmaceutical Sciences, and Administration, graduates here earn above the national average for this program. Across all programs at Roseman University of Health Sciences, the mean median-earnings figure is $150,198, providing internal context for whether this specific field out-earns other options at the same institution.
Debt signals complete the ROI picture. The median cumulative federal loan debt for Pharmacy, Pharmaceutical Sciences, and Administration graduates at Roseman University of Health Sciences is $233,933, which translates to roughly $1,949 per month on a standard 10-year repayment plan. The debt-to-earnings ratio of 1.66 is above the 1.0 threshold, meaning cumulative debt exceeds first-year post-completion earnings. Program-level debt and earnings come from the Department of Education’s College Scorecard FOS release, updated annually.
Earnings Comparison
Program Details
Debt & ROI
Pharmacy, Pharmaceutical Sciences, and Administration at Other Schools
| School | Median Earnings | Median Debt |
|---|---|---|
| University of Southern California | $179,146 | $283,763 |
| University of California-San Diego | $165,543 | $137,223 |
| Pacific University | $151,842 | $216,605 |
| University of Utah | $149,652 | $128,300 |
| University of Michigan-Ann Arbor | $145,758 | — |
| Regis University | $144,658 | $220,926 |
| Thomas Jefferson University | $144,279 | — |
| University of Maryland Eastern Shore | $144,201 | — |
| University of Colorado Denver/Anschutz Medical Campus | $143,753 | $167,617 |
| University of Connecticut | $143,512 | $78,910 |
Other Programs at Roseman University of Health Sciences
| Program | Median Earnings | Median Debt |
|---|---|---|
| Advanced/Graduate Dentistry and Oral Sciences | $268,580 | — |
| Business Administration, Management and Operations | $143,873 | — |
| Pharmacy, Pharmaceutical Sciences, and Administration (current) | $141,336 | $233,933 |
| Dentistry | $137,246 | $444,929 |
| Advanced/Graduate Dentistry and Oral Sciences | $108,223 | — |
| Registered Nursing, Nursing Administration, Nursing Research and Clinical Nursing | $101,932 | $25,000 |
Other Schools with Pharmacy, Pharmaceutical Sciences, and Administration
Quick picks offering the same program — compare side by side
About the Data
Data from the U.S. Department of Education College Scorecard Field of Study file. Earnings are median earnings for graduates after completion, drawn from U.S. Treasury tax records linked to federal financial aid applicants. Institutional characteristics come from IPEDS. Debt figures represent the median cumulative federal loan debt at graduation.
Debt-to-earnings ratio compares cumulative debt to annual earnings. A ratio below 1.0 indicates that annual earnings exceed total debt, generally considered favorable. Estimated monthly payments assume a standard 10-year repayment plan.
Read our methodology — how this data is sourced, computed, and verified.